Published TCIMAIL newest issue No.196
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 319460-85-0 | Product Number: A3479
Axitinib
×
![]()
×
Purity: >95.0%(T)(HPLC)
Synonyms:
- (E)-N-Methyl-2-[[3-[2-(pyridin-2-yl)vinyl]-1H-indazol-6-yl]thio]benzamide
- N-Methyl-2-[[3-[(1E)-2-(pyridin-2-yl)ethenyl]-1H-indazol-6-yl]sulfanyl]benzamide
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 50MG |
€166.00
|
1 | 18 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | A3479 |
| Purity / Analysis Method | >95.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__2__2H__1__8N__4OS = 386.47 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Heat Sensitive |
| CAS RN | 319460-85-0 |
| Reaxys Registry Number | 11333336 |
| MDL Number | MFCD09837898 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Purity(Nonaqueous Titration) | min. 95.0 % |
| Melting point | 217.0 to 221.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 219 °C |
| Maximum Absorption Wavelength | 335(DMSO) nm |
| Solubility in water | Insoluble |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H361 : Suspected of damaging fertility or the unborn child. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P202 : Do not handle until all safety precautions have been read and understood. P201 : Obtain special instructions before use. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection. P308 + P313 : IF exposed or concerned: Get medical advice/ attention. P405 : Store locked up. |
Related Laws:
| RTECS# | CV5586363 |
Transport Information:
| HS Number | 2933399990 |
Application
Axitinib: A Potent and Selective Inhibitor of VEGFR Tyrosine Kinases -1, -2, and -3
Axitinib (AG-013736), a small molecule indazole derivative, is an oral, potent tyrosine kinase receptor inhibitor, which selectively inhibits vascular endothelial growth factor receptors (VEGFR)-1, -2, and -3. These receptors are implicated in pathologic angiogenesis, tumor growth, and cancer progression. Axitinib is shown to inhibit cellular autophosphorylation of VEGF receptors and tumor growth. (The product is for research purpose only.)
References
- Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
- Axitinib for the management of metastatic renal cell carcinoma (a review)
- Clinical Pharmacology of Axitinib (a review)
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.